Evidence map›Paper›PMID 36608404›Full record

ArticleDNA repair2023

Kinome-wide screening uncovers a role for Bromodomain Protein 3 in DNA double-stranded break repair.

Chen Wang, Doug W Chan, Eric A Hendrickson

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Chen WangDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.
Doug W ChanDepartment of Systems Biology, University of Texas, MD Anderson Cancer Center, Houston, TX, 77030.
Eric A HendricksonDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Medical School, Minneapolis, MN, 55455, USA. Electronic address: hendr064@umn.edu.
University of Minnesota Medical Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

Mechanistic insight into genome stability pathwaysR35GM141805 · NIGMS · UNIVERSITY OF VIRGINIA · PI Anja-Katrin Bielinsky · 2021 to 2026
$2.9M
POLQ- and CtIP-regulated telomere fusions and translocations are involved in early events in carcinogenesisR01CA266524 · NCI · UNIVERSITY OF VIRGINIA · PI HENDRICKSON, ERIC A · 2022 to 2025
$2.5M
Ku regulates non-homologous end joining pathways in human somatic cellsR01CA154461 · NCI · UNIVERSITY OF MINNESOTA · PI HENDRICKSON, ERIC A · 2011 to 2015
$1.6M
Mechanism of radial chromosome formation in human premature aging syndrome cellsR21AG077174 · NIA · UNIVERSITY OF VIRGINIA · PI BIELINSKY, ANJA-KATRIN, HENDRICKSON, ERIC A · 2023 to 2024
$444k
NCI NIH HHS R01 CA154461NCI NIH HHS R01 CA266524NIA NIH HHS R21 AG077174
6 · The paper itself

Abstract

Double-stranded breaks (DSBs) are toxic DNA damage and a serious threat to genomic integrity. Thus, all living organisms have evolved multiple mechanisms of DNA DSB repair, the two principal ones being classical-non homologous end joining (C-NHEJ), and homology dependent recombination (HDR). In mammals, C-NHEJ is the predominate DSB repair pathway, but how a cell chooses to repair a particular DSB by a certain pathway is still not mechanistically clear. To uncover novel regulators of DSB repair pathway choice, we performed a kinome-wide screen in a human cell line engineered to express a dominant-negative C-NHEJ factor. The intellectual basis for such a screen was our hypothesis that a C-NHEJ-crippled cell line might need to upregulate other DSB repair pathways, including HDR, in order to survive. This screen identified Bromodomain-containing Protein 3 (BRD3) as a protein whose expression was almost completely ablated specifically in a C-NHEJ-defective cell line. Subsequent experimentation demonstrated that BRD3 is a negative regulator of HDR as BRD3-null cell lines proved to be hyper-recombinogenic for gene conversion, sister chromatid exchanges and gene targeting. Mechanistically, BRD3 appears to be working at the level of Radiation Sensitive 51 (RAD51) recruitment. Overall, our results demonstrate that BRD3 is a novel regulator of human DSB repair pathway choice.

Indexed as

DNA-Binding ProteinsDNA Breaks, Double-StrandedAnimalsDNADNA End-Joining RepairDNA RepairHumansMammalsDNADNA-Binding ProteinsBRD3HDRKinomePRKDCRAD51

Identifiers

PMID36608404
PMCPMC10353298
OpenAlexW4312204581

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.